Landon Hope
Resident Physician
Also affiliated: Texas Tech University (2020–2023); Lubbock Christian University (2020); Texas Tech University Health Sciences Center (2020–2022)
Faculty Researcher
College of Medicine Administration
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Landon Hope is a resident physician at the University of Arkansas for Medical Sciences, College of Medicine Administration. His research has focused on dermatological conditions, particularly keratinocyte carcinomas, and their treatment. He has investigated clinicopathological predictors for Mohs micrographic surgery stages and analyzed Mohs Appropriate Use Criteria scores in relation to treatment outcomes for keratinocyte carcinoma, reviewing data from over 11,000 tumors. His publications also include case studies on unusual skin reactions, such as a pseudolymphomatous reaction to blue tattoo pigment potentially precipitated by COVID-19 vaccination and a pruritic papule presentation. His work contributes to the understanding of skin cancer management and the diagnosis of various dermatological presentations.
Metrics
- h-index: 2
- Publications: 10
- Citations: 10
Selected Publications
-
Mohs Appropriate Use Criteria Scores and Treatment of Keratinocyte Carcinoma: Review of 11,145 Tumors (2023)
-
Mohs micrographic surgery for keratinocyte carcinomas: clinicopathological predictors of the number of stages (2023)
Collaboration Network
Top Collaborators
- Mohs micrographic surgery for keratinocyte carcinomas: clinicopathological predictors of the number of stages
- Mohs Appropriate Use Criteria Scores and Treatment of Keratinocyte Carcinoma: Review of 11,145 Tumors
- Mohs micrographic surgery for keratinocyte carcinomas: clinicopathological predictors of the number of stages
- Mohs Appropriate Use Criteria Scores and Treatment of Keratinocyte Carcinoma: Review of 11,145 Tumors
- Mohs micrographic surgery for keratinocyte carcinomas: clinicopathological predictors of the number of stages
- Mohs Appropriate Use Criteria Scores and Treatment of Keratinocyte Carcinoma: Review of 11,145 Tumors
Similar Researchers
Based on overlapping research topics